SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-09-027078
Filing Date
2009-05-15
Accepted
2009-05-15 11:34:36
Documents
6
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 v149545_10q.htm 10-Q 963539
2 GRAPHIC chart.jpg GRAPHIC 20950
3 v149545_ex31-1.htm EX-31.1 9964
4 v149545_ex31-2.htm EX-31.2 9822
5 v149545_ex32-1.htm EX-32.1 5333
6 v149545_ex32-2.htm EX-32.2 5315
  Complete submission text file 0001144204-09-027078.txt   1024536
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

IRS No.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32581 | Film No.: 09830292
SIC: 2834 Pharmaceutical Preparations